Latest Press Releases
Mar 7, 2017 • 7:00am EST
Synthetic Biologics to Present at the 29th Annual ROTH Conference
ROCKVILLE, Md., March 7, 2017 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, announced today that Jeffrey Riley, President & Chief Executive Officer, is scheduled to present at the 29th Annual ROTH Conference being held March 12-15 at the Ritz-Carlton, Laguna Niguel in Dana Point, CA. Mr. Riley is scheduled to present on Wednesday, March 15, 2016 at 8:00 a.m. (Pacific Time)/11:00 a.m. (Eastern Time). A live webcast ...